首页 | 本学科首页   官方微博 | 高级检索  
     

链激酶研究概况及其进展
引用本文:张华山,闫俊鹏,齐义鹏,李亚芳,余响华. 链激酶研究概况及其进展[J]. 氨基酸和生物资源, 2006, 28(4): 71-73. DOI: 10.3969/j.issn.1006-8376.2006.04.020
作者姓名:张华山  闫俊鹏  齐义鹏  李亚芳  余响华
作者单位:湖北工业大学生物工程学院,武汉,430068;武汉大学生命科学学院,武汉,430072
摘    要:链激酶(Streptok inase,SK)是世界上最早发现的纤维蛋白酶原激活剂,也是最早作为临床药品治疗血栓性疾病的溶栓酶。它是由A,C,G群链球菌中β-溶血性链球菌分泌的胞外非酶蛋白质,能和纤溶酶原结合,将纤溶酶原激活为纤溶酶,具有溶解血栓的作用。本文详细综述了该酶的性质、在溶栓酶中的地位、研究历史、作用机理等。此外,由于它有半衰期短、不具有纤维蛋白特异性、治疗后出血和血栓易复发的缺点,所以有必要用基因工程的手段进行改造,以达到更好的治疗效果。

关 键 词:链激酶  重组链激酶  纤溶酶原
文章编号:1006-8376(2006)04-0071-03
收稿时间:2006-06-27
修稿时间:2006-06-27

General Situation and Latest Progress on Streptokinase
ZHANG Hua-Shan,YAN Jun-Peng,QI Yi-peng,LI Ya-fang,YU Xiang-hua. General Situation and Latest Progress on Streptokinase[J]. Amino Acids & Biotic Resources, 2006, 28(4): 71-73. DOI: 10.3969/j.issn.1006-8376.2006.04.020
Authors:ZHANG Hua-Shan  YAN Jun-Peng  QI Yi-peng  LI Ya-fang  YU Xiang-hua
Affiliation:1. College of Bioengineering of Hubei University of Technology, Wuhan 430068 ; 2. College of Life Science, WuHan University, Wuhan 430072, China
Abstract:Streptokinase(SK) was discovered as the first plasminogen activator in the world,and it was the earliest clinical agent to cure thrombus.Streptokinase is an extracellular protein which is produced by β-hemolytic streptococci group A,C and G.It binds to plasminogen(Pg) to form a complex that converts substrate Pg to plasmin.And it can lyse blood clots.We summarized the characteristics、status、research history、catalytic mechanism of it.In addition,Because of its short half-life、bleeding、non fibrin-specific and recurring rate,it is necessary to reconstruct it by gene engineering to obtain better curative effect.
Keywords:streptokinase  recombinant streptokinase  plasminogen
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号